Evaxion A/S
Develops AI-powered, personalized vaccines for cancer and infectious diseases.
EVAX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US29970R3030
- LEI:
- Country:
- United States of America
- Address:
- DR NEERGAARDS VEJ 5F, 0 HOERSHOLM
- Website:
- https://evaxion.ai/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Evaxion A/S is a clinical-stage TechBio company that develops AI-powered immunotherapies. Its core is the proprietary and clinically validated AI-Immunology™ platform, which decodes the human immune system to accelerate the discovery, design, and development of novel vaccines. The company focuses on creating personalized and precision vaccines for cancer and infectious diseases. By using advanced AI prediction models, the platform can rapidly identify therapeutically relevant vaccine targets, enabling the development of tailored candidates to meet specific disease signatures. Its pipeline includes assets in preclinical and clinical development stages for oncology and infectious diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Evaxion A/S filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Evaxion A/S
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Evaxion A/S via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
